HARBINGERHX Trademark

Trademark Overview

On Wednesday, November 29, 2023, a trademark application was filed for HARBINGERHX with the United States Patent and Trademark Office. The USPTO has given the HARBINGERHX trademark a serial number of 98290220. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, June 1, 2026. This trademark is owned by Harbinger Health, Inc.. The HARBINGERHX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; drug discovery platform services

General Information

Serial Number98290220
Word MarkHARBINGERHX
Filing DateWednesday, November 29, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, June 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements

Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; drug discovery platform services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 20, 2024
Primary Code042
First Use Anywhere DateThursday, September 28, 2023
First Use In Commerce DateThursday, September 28, 2023

Trademark Owner History

Party NameHarbinger Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138
US
Party NameHarbinger Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138
US

Trademark Events

Event DateEvent Description
Thursday, November 30, 2023NEW APPLICATION ENTERED
Friday, February 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2024ASSIGNED TO EXAMINER
Friday, June 28, 2024NON-FINAL ACTION WRITTEN
Friday, June 28, 2024NON-FINAL ACTION E-MAILED
Friday, June 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 19, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, December 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 5, 2025NON-FINAL ACTION WRITTEN
Wednesday, February 5, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 26, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, November 26, 2025SOU EXTENSION 1 FILED
Wednesday, November 26, 2025SOU EXTENSION 1 GRANTED
Thursday, November 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 28, 2026TEAS STATEMENT OF USE RECEIVED
Wednesday, January 28, 2026USE AMENDMENT FILED
Thursday, May 28, 2026STATEMENT OF USE PROCESSING COMPLETE
Monday, June 1, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 1, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

harbingerhx research development field biotechnology scientific pharmaceuticals platform biology computational platforms